MedPath

blood level can be increased on taking an Ayurvedic Formulation "Vidangadi Lauha" in Girls Of Age Group 10-16 Years.

Phase 1/2
Completed
Conditions
Other iron deficiency anemias,
Registration Number
CTRI/2018/06/014376
Lead Sponsor
All India Institute of Ayurveda
Brief Summary

RESEARCH QUESTION

What is the efficacy of the oral administration of Vidangadi Lauha syrup/malt in managing Pandu Roga (IDA) in comparison with that of Iron and Folic acid in adolescent girls?

HYPOTHESIS

Blood haemoglobin level is improved and sign and symptoms of Pandu Roga (IDA) are reduced in adolescent girls who receive daily Vidangadi Lauha syrup/malt for a period of 3 months with the dose of 10ml OD, compared with the adolescent girls who receive Iron and Folic acid with the dose of iron-60mg and folic acid-400microgram/day for same period of time.

Null hypothesis-

H0: In the proposed clinical trial null hypothesis is that the efficacy of Vidanagadi Lauha is no better, on average in comparison with the Iron and Folic acid.

Alternate hypothesis-

H1: The alternative hypothesis is that the efficacy of Vidangadi Lauha is better in comparison with that of Iron and Folic acid.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Female patients between the age group of 10-16 years.
  • Patients presenting clinical sign and symptoms of Pandu Roga (IDA).
  • Patients with mild to moderate anaemia (haemoglobin level from 11g/dl to 8g/dl).
  • Patients/Parents giving consent to participate in the study.
Exclusion Criteria
  • Females below 10 years and above 16 years of age.
  • Patients with severe anaemia (haemoglobin level <8g/dl) requiring hospitalization and BT, patients of T.B, D.M, heart diseases, liver diseases and other chronic systemic disorders.
  • Conditions like menorrhagia, piles, fissures and other haemorrhagic conditions.
  • Anaemia in case of defective absorption due to gastrectomy, sprue syndrome.
  • Any other systemic disease wherein anaemia is one among the presenting complaints.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in Haemoglobin g/dl3 Months
Secondary Outcome Measures
NameTimeMethod
Reduction in signs and symptoms of Pandu Roga (IDA).Improvement in CBC, Serum Iron, Serum Ferritin and TIBC.

Trial Locations

Locations (1)

All India Institute Of Ayurveda

🇮🇳

Delhi, DELHI, India

All India Institute Of Ayurveda
🇮🇳Delhi, DELHI, India
Dr Monika
Principal investigator
9711728156
ayurmonika@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.